Julia Publicover

Director, Translational Research & Innovation University Health Network

Julia Publicover, MSc, PMP, is Director of Translational Research and Innovation at the University Health Network (UHN) in Toronto, where she leads initiatives across molecular imaging and theranostics. Her portfolio spans core facilities including QIPCM and the UHN Radiotheranostics Core, supporting clinical trials, radiopharmaceutical production, and imaging science. With a background in medical physics and radioisotope development, Julia focuses on translating innovation into clinical impact. She works closely with industry, clinicians, and researchers to build integrated ecosystems that accelerate the development, evaluation, and adoption of targeted radiopharmaceuticals within large academic health systems.

Seminars

Tuesday 1st December 2026
How UHN & Eli Lilly Are Building a Translational Ecosystem to Accelerate Radiopharmaceutical Development
11:30 am
  • Sharing how integrated translational infrastructure is accelerating radiopharmaceutical development from discovery through to standard of care
  • Exploring the operational foundations required to support Phase 0 studies, clinical trials and therapeutic innovation
  • Identifying the capabilities needed to translate promising radiopharmaceuticals into routine clinical practice
Julia Publicover